Naoto Katakami, Tomoya Mita, Hidenori Yoshii, Toshihiko Shiraiwa, Tetsuyuki Yasuda, Yosuke Okada, Akira Kurozumi, Masahiro Hatazaki, Hideaki Kaneto, Takeshi Osonoi, et al. Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial. Cardiovascular diabetology. 2023. 22. 1. 143-143
CHIKA HORIKAWA, MITSUYOSHI TAKAHARA, NAOTO KATAKAMI, YASUNAGA TAKEDA, MIZUKI TAKEUCHI, KAZUYA FUJIHARA, HIROAKI SUZUKI, KINSUKE TSUDA, NARIHITO YOSHIOKA, HITOSHI SHIMANO, et al. 1381-P: Effect of Dietary Potassium Intake and Its Interaction with Sodium Intake on Risk of Developing Cardiovascular Disease (CVD) in Persons with Type 2 Diabetes (T2D)-Japan Diabetes Complication and Its Prevention Prospective Study (JDCP Study). Diabetes. 2023. 72. Supplement_1
Mitsuyoshi Takahara, Toshihiko Shiraiwa, Naoto Katakami, Yoshifumi Maeno, Kaoru Yamamoto, Yuka Shiraiwa, Yoko Yoshida, Junji Kozawa, Iichiro Shimomura. Daily Glucose Profiles after Switching from Injectable to Oral Semaglutide in Patients with Type 2 Diabetes Mellitus. Internal medicine (Tokyo, Japan). 2023